Are Peptides Safe for Women?

Whether a peptide is safe depends on which one it is and where it comes from: some are FDA-approved, most wellness peptides are not, human data on them is limited, and the biggest risks come from unregulated online sellers. A licensed prescriber and a state-licensed pharmacy remove the riskiest part, which is buying, mixing and injecting a vial nobody checked. You can take the quiz so our clinical team can see whether a peptide fits your goal.

Are peptides FDA-approved?

Some are, and most wellness peptides are not. Peptides are short chains of amino acids, the building blocks of protein. Many peptide drugs went through a full approval process that checks safety and effectiveness. Alongside them is a "gray market" of unapproved peptides sold largely outside regulatory oversight, according to a 2026 review of peptide therapies.

Semaglutide and tirzepatide are FDA-approved peptides. FDA approved them based on trials in people with higher body weights, many of whom had other health conditions.

Many wellness peptides are compounded, which means a licensed pharmacist or physician mixes the medicine for one patient. Compounded drugs are not FDA-approved, so FDA does not review their safety, effectiveness or quality before they are sold.

That picture is shifting. On October 28, 2026, HHS filed a draft peptide compounding policy, scheduled to publish October 30, 2026. It says HHS does not intend to take enforcement action against state-licensed pharmacies, federal facilities or licensed physicians that compound certain peptides listed in the policy. HHS says it may revisit the policy if a safety or quality problem appears. A draft policy is not FDA approval.

How you use a peptide matters too. FDA lists GHK-Cu, the copper peptide used for skin and hair, as under evaluation for compounding except when injected, and lists NAD in the same category. For substances in this category, FDA does not intend to take action against compounders who meet the conditions in its guidance. FDA plans to consult its compounding advisory committee about GHK-Cu before the end of February 2027.

Our clinical team reviews your goal and health history and decides whether a peptide from our lineup fits your plan. You can see the peptides we cover on our body treatments page.

What are the real risks?

The biggest risks come from how a peptide is made, bought and injected, and from how little human data exists for many of them.

What women share

We read 195 threads posted from October 2025 to October 2026, 181 in r/Peptides and 14 in r/30PlusSkinCare. 81 of 195 named BPC-157, NAD+, tesamorelin, sermorelin or ipamorelin, and 39 of those 81 named BPC-157, which made it the most talked-about peptide.

31 of 195 threads were about copper peptides (GHK-Cu). 22 of those 31 were about injecting it and 9 of 31 were about a serum. Most of the talk was about injecting, which is the route FDA's risk note covers. The on-skin route is the one FDA keeps under evaluation.

In these threads, "pip" means pain after the injection. One poster who injected GHK-Cu and a GHK-Cu, BPC-157 and TB-500 blend over a year described "red to bruise-ish spots that were hard and hot and a mix of painful and itchy" in this r/Peptides thread.

Using many peptides at once makes it hard to tell what is causing a problem. One poster taking several peptides for sleep wrote in r/Peptides: "Some days I'll have good energy, but most days I feel tired but wired." When your clinical team knows everything you take, they have a better chance of working out which one is behind a problem.

How can you lower the risk?

1. Get peptides through a licensed prescriber. Skipping the prescriber means nobody checks your other medicines for interactions or follows up on how you are doing.
2. Use a state-licensed pharmacy. FDA's BeSafeRx page helps you look up a state-licensed online pharmacy and spot the warning signs of unsafe sites.
3. Ask about the certificate of analysis. This is a lab document that shows what is in the raw ingredient. FDA requires ingredients used in compounding to come with a valid certificate of analysis and to be made in an FDA-registered facility. Here is how to read a peptide certificate of analysis.
4. Don't trust a certificate on a seller's website by itself. Gray-market sellers use certificates of analysis and "research use only" labels to look trustworthy while selling for human use. Skip any vial sold as "research use only" or "not for human consumption". Here is how a legitimate peptide clinic differs from a research seller.
5. Report side effects. If something unexpected happens, tell your clinical team and report it to FDA through MedWatch.

Who should not take peptides?

Women who are underweight or have an eating disorder should not take semaglutide or tirzepatide. A licensed prescriber would turn them down, but online "peptide" sellers skip that check.

Women who are leaner and healthier than the people in the trials face an open question. Researchers say it is unknown whether the benefits of semaglutide and tirzepatide still outweigh the risks in younger, thinner, healthier people.

Women taking other medicines that lower blood sugar need extra care. Starting semaglutide or tirzepatide can raise the risk of low blood sugar, so your clinical team needs your full medication list.

Don't take peptides if you plan to keep them from your care team. People often leave peptides off their medication list because they don't think of them as medicine, and then their clinicians may blame symptoms on something else.

Take the quiz to tell our clinical team your goal and health history. They can see which peptide, if any, fits your plan, and get it to you through a prescription instead of a research vial.